Glaxosmithkline signs agreement with Lonza to manufacture drug compounds
GlaxoSmithKline PLC says it has signed an agreement with Lonza for the Swiss company to manufacture a number of drug compounds.
After knowingly selling drugs with questionable safety for years, drug maker GlaxoSmithKline has agreed to a $750 million settlement.